4.6 Article

Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study

Related references

Note: Only part of the references are listed.
Article Oncology

Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening

Lasse Kaalby et al.

Summary: This study found that screening participants with detectable fecal hemoglobin had higher mortality rates and different causes of death compared to those without. Fecal hemoglobin may serve as a marker for diseases not directly related to colorectal cancer and may be targeted for preventive measures in the future.

CANCERS (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Gastroenterology & Hepatology

Faecal immunochemical test outside colorectal cancer screening?

Noel Pin-Vieito et al.

Summary: FIT is widely used as a biomarker for colorectal cancer diagnosis and plays a crucial role in screening and surveillance. This review summarizes the diagnostic efficacy of FIT in symptomatic patients and post-adenoma resection, as well as discusses the potential impact of FIT strategies on healthcare resources and CRC prognosis.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Review Medicine, General & Internal

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Karina W. Davidson et al.

Summary: Colorectal cancer is a significant cause of cancer-related deaths, with high incidence in adults aged 65 to 74. Screening is recommended for adults aged 50 to 75 with substantial net benefit, for those aged 45 to 49 with moderate net benefit, and selective screening is advised for adults aged 76 to 85.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Gastroenterology & Hepatology

Strategies for Colorectal Cancer Screening

Uri Ladabaum et al.

GASTROENTEROLOGY (2020)

Review Oncology

Epidemiology and risk factors of colorectal cancer in China

Yong Yang et al.

CHINESE JOURNAL OF CANCER RESEARCH (2020)

Review Gastroenterology & Hepatology

Non-Invasive Colorectal Cancer Screening: An Overview

Melanie Tepus et al.

GASTROINTESTINAL TUMORS (2020)

Article Multidisciplinary Sciences

Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China

Guozhen Lin et al.

SCIENTIFIC REPORTS (2019)

Article Public, Environmental & Occupational Health

Contribution of the OC Sensor® immunoassay in comparison to the Hemoccult II® guaiac-test in organized colorectal cancer screening

Carole Vitellius et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2019)

Article Oncology

An early report of a screening program for colorectal cancer in Guangzhou, China

Yujing Fang et al.

ANNALS OF TRANSLATIONAL MEDICINE (2019)

Article Medicine, General & Internal

Colonoscopy and Colorectal Cancer Mortality in the Veterans Affairs Health Care System A Case-Control Study

Charles J. Kahi et al.

ANNALS OF INTERNAL MEDICINE (2018)

Article Oncology

Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society

Andrew M. D. Wolf et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Gastroenterology & Hepatology

Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality

Gillian Libby et al.

Review Gastroenterology & Hepatology

Colorectal cancer screening: An updated review of the available options

Iyad A. Issa et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Article Oncology

Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013

Zhixun Yang et al.

CHINESE JOURNAL OF CANCER RESEARCH (2017)

Article Oncology

Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia

Feng Niu et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Article Medicine, General & Internal

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening A Retrospective Cohort Study

Christopher D. Jensen et al.

ANNALS OF INTERNAL MEDICINE (2016)

Article Gastroenterology & Hepatology

Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy

Paolo Giorgi Rossi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Thomas F. Imperiale et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Multidisciplinary Sciences

Cost-Effectiveness of Colorectal Cancer Screening Protocols in Urban Chinese Populations

Weidong Huang et al.

PLOS ONE (2014)

Review Gastroenterology & Hepatology

Participation in colorectal cancer screening trials after first-time invitation: a systematic review

C. Khalid-de Bakker et al.

ENDOSCOPY (2011)

Article Gastroenterology & Hepatology

The Reduction in Colorectal Cancer Mortality After Colonoscopy Varies by Site of the Cancer

Harminder Singh et al.

GASTROENTEROLOGY (2010)

Article Oncology

Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging

JB O'Connell et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)